{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,2]],"date-time":"2026-08-02T06:58:15Z","timestamp":1785653895880,"version":"3.56.0"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,15]],"date-time":"2025-02-15T00:00:00Z","timestamp":1739577600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002873","name":"Chulalongkorn University","doi-asserted-by":"publisher","award":["64.310\/436\/2565"],"award-info":[{"award-number":["64.310\/436\/2565"]}],"id":[{"id":"10.13039\/501100002873","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002873","name":"Chulalongkorn University","doi-asserted-by":"publisher","award":["HEA663000016"],"award-info":[{"award-number":["HEA663000016"]}],"id":[{"id":"10.13039\/501100002873","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010804","name":"Faculty of Medicine, Prince of Songkla University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010804","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004776","name":"Faculty of Medicine, Chulalongkorn University","doi-asserted-by":"publisher","award":["RA66\/016"],"award-info":[{"award-number":["RA66\/016"]}],"id":[{"id":"10.13039\/501100004776","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Advanced Research"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.jare.2025.02.021","type":"journal-article","created":{"date-parts":[[2025,2,16]],"date-time":"2025-02-16T18:19:59Z","timestamp":1739729999000},"page":"543-553","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Autoimmune responses to myelin-associated proteins as diagnostic and prognostic biomarkers of relapsing-remitting multiple sclerosis: Associations with human herpesvirus-6 and Epstein-Barr virus reactivation"],"prefix":"10.1016","volume":"78","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2925-9334","authenticated-orcid":false,"given":"Aristo","family":"Vojdani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abbas F.","family":"Almulla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8687-9762","authenticated-orcid":false,"given":"Elroy","family":"Vojdani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1208-6070","authenticated-orcid":false,"given":"Yingqian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Maes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.jare.2025.02.021_b0005","first-page":"442","article-title":"Relapsing-Remitting Multiple Sclerosis","volume":"73","author":"Niino","year":"2021","journal-title":"Brain Nerve"},{"key":"10.1016\/j.jare.2025.02.021_b0010","article-title":"A Global Epidemiological Forecast of Multiple Sclerosis and Disease Subtypes (S16.002)","volume":"88(16_supplement):S16.002","author":"Goonesekera","year":"2017","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.jare.2025.02.021_b0015","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1212\/WNL.0000000000000560","article-title":"Defining the clinical course of multiple sclerosis: the 2013 revisions","volume":"83","author":"Lublin","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.jare.2025.02.021_b0020","first-page":"3","volume":"8","author":"Multiple","year":"2018","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"15","key":"10.1016\/j.jare.2025.02.021_b0025","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1212\/WNL.0000000000201223","article-title":"Preventing Neurodegeneration in Multiple Sclerosis Is Required From the Earliest Stages of the Disease","volume":"99","author":"Villoslada","year":"2022","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.jare.2025.02.021_b0030","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/00019052-199906000-00008","article-title":"Axonal pathology in multiple sclerosis: relationship to neurologic disability","volume":"12","author":"Trapp","year":"1999","journal-title":"Curr Opin Neurol"},{"issue":"3","key":"10.1016\/j.jare.2025.02.021_b0035","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1212\/CON.0000000000000725","article-title":"Multiple Sclerosis Risk Factors and Pathogenesis","volume":"25","author":"Nourbakhsh","year":"2019","journal-title":"Continuum (Minneap Minn)"},{"issue":"1","key":"10.1016\/j.jare.2025.02.021_b0040","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s12035-015-9648-6","article-title":"Genetic, Immune-Inflammatory, and Oxidative Stress Biomarkers as Predictors for Disability and Disease Progression in Multiple Sclerosis","volume":"54","author":"Kallaur","year":"2017","journal-title":"Mol Neurobiol"},{"issue":"2","key":"10.1016\/j.jare.2025.02.021_b0045","doi-asserted-by":"crossref","first-page":"83","DOI":"10.11138\/FNeur\/2017.32.2.083","article-title":"HLA-DRB1*15 association with multiple sclerosis is confirmed in a multigenerational Italian family","volume":"32","author":"Mosca","year":"2017","journal-title":"Funct Neurol"},{"issue":"1","key":"10.1016\/j.jare.2025.02.021_b0050","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s40120-017-0086-4","article-title":"Vitamin D and Multiple Sclerosis: A Comprehensive Review","volume":"7","author":"Sintzel","year":"2018","journal-title":"Neurol Ther"},{"issue":"4","key":"10.1016\/j.jare.2025.02.021_b0055","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1177\/1352458517690270","article-title":"A systematic review of modifiable risk factors in the progression of multiple sclerosis","volume":"23","author":"Hempel","year":"2017","journal-title":"Mult Scler"},{"key":"10.1016\/j.jare.2025.02.021_b0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2023.106031","article-title":"Association between human herpesviruses and multiple sclerosis: A systematic review and meta-analysis","volume":"177","author":"Khalesi","year":"2023","journal-title":"Microb Pathog"},{"issue":"7","key":"10.1016\/j.jare.2025.02.021_b0065","doi-asserted-by":"crossref","DOI":"10.3390\/brainsci13071073","article-title":"Mood Symptoms and Chronic Fatigue Syndrome Due to Relapsing-Remitting Multiple Sclerosis Are Associated with Immune Activation and Aberrations in the Erythron","volume":"13","author":"Almulla","year":"2023","journal-title":"Brain Sci"},{"issue":"4","key":"10.1016\/j.jare.2025.02.021_b0070","doi-asserted-by":"crossref","first-page":"2950","DOI":"10.1007\/s12035-016-9846-x","article-title":"Cytokine Profile in Patients with Progressive Multiple Sclerosis and Its Association with Disease Progression and Disability","volume":"54","author":"Kallaur","year":"2017","journal-title":"Mol Neurobiol"},{"issue":"8","key":"10.1016\/j.jare.2025.02.021_b0075","doi-asserted-by":"crossref","first-page":"5191","DOI":"10.1007\/s12035-015-9443-4","article-title":"Immune-Inflammatory and Oxidative and Nitrosative Stress Biomarkers of Depression Symptoms in Subjects with Multiple Sclerosis: Increased Peripheral Inflammation but Less Acute Neuroinflammation","volume":"53","author":"Kallaur","year":"2016","journal-title":"Mol Neurobiol"},{"issue":"4","key":"10.1016\/j.jare.2025.02.021_b0080","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.autrev.2009.08.002","article-title":"The myelin-associated oligodendrocytic basic protein (MOBP) as a relevant primary target autoantigen in multiple sclerosis","volume":"9","author":"Kaushansky","year":"2010","journal-title":"Autoimmun Rev"},{"issue":"4","key":"10.1016\/j.jare.2025.02.021_b0085","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1006\/jaut.1998.0202","article-title":"T-cell Responses to Myelin Antigens in Multiple Sclerosis; Relevance of the Predominant Autoimmune Reactivity to Myelin Oligodendrocyte Glycoprotein","volume":"11","author":"de Rosbo","year":"1998","journal-title":"J Autoimmun"},{"issue":"1","key":"10.1016\/j.jare.2025.02.021_b0090","first-page":"65","article-title":"Autoreactive T lymphocytes in multiple sclerosis: pathogenic role and therapeutic targeting","volume":"99","author":"Stinissen","year":"1999","journal-title":"Acta Neurol Belg"},{"issue":"7","key":"10.1016\/j.jare.2025.02.021_b0095","doi-asserted-by":"crossref","first-page":"579","DOI":"10.2174\/1389203724666230717124101","article-title":"The Fulcrum of Demyelination in Multiple Sclerosis","volume":"24","author":"Ganesan","year":"2023","journal-title":"Curr Protein Pept Sci"},{"issue":"4","key":"10.1016\/j.jare.2025.02.021_b0100","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1046\/j.1365-2796.2003.01203.x","article-title":"Antibodies to myelin basic protein, myelin oligodendrocytes peptides, alpha-beta-crystallin, lymphocyte activation and cytokine production in patients with multiple sclerosis","volume":"254","author":"Vojdani","year":"2003","journal-title":"J Intern Med"},{"issue":"9","key":"10.1016\/j.jare.2025.02.021_b0105","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/nri3871","article-title":"Immunopathology of multiple sclerosis","volume":"15","author":"Dendrou","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jare.2025.02.021_b0110","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1146\/annurev-cellbio-100617-062518","article-title":"Non-Antibody-Secreting Functions of B Cells and Their Contribution to Autoimmune Disease","volume":"35","author":"Getahun","year":"2019","journal-title":"Annu Rev Cell Dev Biol"},{"key":"10.1016\/j.jare.2025.02.021_b0115","series-title":"Tuosto L","first-page":"13","author":"Kunkl","year":"2022"},{"key":"10.1016\/j.jare.2025.02.021_b0120","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.757302","article-title":"Cumulative Roles for Epstein-Barr Virus, Human Endogenous Retroviruses, and Human Herpes Virus-6 in Driving an Inflammatory Cascade Underlying MS Pathogenesis","volume":"12","author":"Meier","year":"2021","journal-title":"Front Immunol"},{"issue":"6","key":"10.1016\/j.jare.2025.02.021_b0125","doi-asserted-by":"crossref","DOI":"10.3390\/v12060643","article-title":"Role of Viruses in the Pathogenesis of Multiple Sclerosis","volume":"12","author":"Tarlinton","year":"2020","journal-title":"Viruses"},{"key":"10.1016\/j.jare.2025.02.021_b0130","doi-asserted-by":"crossref","unstructured":"Almulla AF, Vojdani A, Zhang Y, Vojdani E, Maes M. Reactivation of Human Herpesvirus 6 and Epstein-Barr Virus in relapsing remitting multiple sclerosis: association with disabilities, disease progression, and inflammatory processes. medRxiv. 2024:2024.09.10.24313388. doi: 10.1101\/2024.09.10.24313388.","DOI":"10.1101\/2024.09.10.24313388"},{"key":"10.1016\/j.jare.2025.02.021_b0135","doi-asserted-by":"crossref","unstructured":"Maes M, Almulla AF, Vojdani E, Dzhambazova E, Stoyanov D, Zhang Y, et al. Chronic fatigue syndrome, depression, and anxiety symptoms due to relapsing-remitting multiple sclerosis are associated with reactivation of Epstein-Barr virus and Human Herpesvirus 6. medRxiv. 2024:2024.10.12.24315393. doi: 10.1101\/2024.10.12.24315393.","DOI":"10.1101\/2024.10.12.24315393"},{"issue":"6","key":"10.1016\/j.jare.2025.02.021_b0140","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.1128\/JVI.02260-10","article-title":"Factors supporting intrathecal humoral responses following viral encephalomyelitis","volume":"85","author":"Phares","year":"2011","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.jare.2025.02.021_b0145","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1128\/CMR.19.1.80-94.2006","article-title":"Molecular Mimicry, Bystander Activation, or Viral Persistence: Infections and Autoimmune Disease","volume":"19","author":"Fujinami Robert","year":"2006","journal-title":"Clin Microbiol Rev"},{"issue":"2","key":"10.1016\/j.jare.2025.02.021_b0150","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/ana.22366","article-title":"Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria","volume":"69","author":"Polman","year":"2011","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jare.2025.02.021_b0155","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.33.11.1444","article-title":"Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS)","author":"Kurtzke","year":"198333111444","journal-title":"Neurology"},{"issue":"7","key":"10.1016\/j.jare.2025.02.021_b0160","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1212\/01.WNL.0000156155.19270.F8","article-title":"Multiple Sclerosis Severity Score: using disability and disease duration to rate disease severity","volume":"64","author":"Roxburgh","year":"2005","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.jare.2025.02.021_b0165","doi-asserted-by":"crossref","first-page":"3684","DOI":"10.1038\/s41598-018-22058-6","article-title":"Antibodies to a strain-specific citrullinated Epstein-Barr virus peptide diagnoses rheumatoid arthritis","volume":"8","author":"Trier","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.jare.2025.02.021_b0170","doi-asserted-by":"crossref","unstructured":"Almulla AF, Maes M, Zhou B, Al-Hakeim HK, Vojdani A. Brain-targeted autoimmunity is strongly associated with Long COVID and its chronic fatigue syndrome as well as its affective symptoms. medRxiv. 2023:2023.10.04.23296554. doi: 10.1101\/2023.10.04.23296554.","DOI":"10.1101\/2023.10.04.23296554"},{"issue":"7900","key":"10.1016\/j.jare.2025.02.021_b0175","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/s41586-022-04432-7","article-title":"Clonally expanded B cells in multiple sclerosis bind EBV EBNA1 and GlialCAM","volume":"603","author":"Lanz","year":"2022","journal-title":"Nature"},{"issue":"13","key":"10.1016\/j.jare.2025.02.021_b0180","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1177\/1352458513485653","article-title":"Serum autoantibodies to myelin peptides distinguish acute disseminated encephalomyelitis from relapsing- Remitting multiple sclerosis","volume":"19","author":"Van Haren","year":"2013","journal-title":"Mult Scler J"},{"issue":"9","key":"10.1016\/j.jare.2025.02.021_b0185","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1177\/1352458507084431","volume":"13","author":"Amor","year":"2007","journal-title":"Mult Scler"},{"issue":"4","key":"10.1016\/j.jare.2025.02.021_b0190","article-title":"Serum antibodies to phosphatidylcholine in MS","volume":"7","author":"S\u00e1daba","year":"2020","journal-title":"Neurology: Neuroimmunology and NeuroInflammation"},{"issue":"1","key":"10.1016\/j.jare.2025.02.021_b0195","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24010894","article-title":"Myelin Basic Protein in Oligodendrocyte-Derived Extracellular Vesicles as a Diagnostic and Prognostic Biomarker in Multiple Sclerosis: A Pilot Study","volume":"24","author":"Agliardi","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"4","key":"10.1016\/j.jare.2025.02.021_b0200","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1056\/NEJMoa063602","article-title":"Lack of association between antimyelin antibodies and progression to multiple sclerosis","volume":"356","author":"Kuhle","year":"2007","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.jare.2025.02.021_b0205","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1177\/135245850100700503","article-title":"Anti-MOG and anti-MBP antibody subclasses in multiple sclerosis","volume":"7","author":"Egg","year":"2001","journal-title":"Mult Scler"},{"issue":"2","key":"10.1016\/j.jare.2025.02.021_b0210","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1155\/2005\/826817","article-title":"Serum levels of anti-myelin antibodies in relapsing-remitting multiple sclerosis patients during different phases of disease activity and immunomodulatory therapy","volume":"21","author":"Angelucci","year":"2005","journal-title":"Dis Markers"},{"key":"10.1016\/j.jare.2025.02.021_b0215","doi-asserted-by":"crossref","unstructured":"Perini P, Ranzato F, Calabrese M, Battistin L, Gallo P. Intrathecal IgM production at clinical onset correlates with a more severe disease course in multiple sclerosis. Journal of Neurology, Neurosurgery & Psychiatry. 2006;77(8):953. doi: 10.1136\/jnnp.2005.086116.","DOI":"10.1136\/jnnp.2005.086116"},{"key":"10.1016\/j.jare.2025.02.021_b0220","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.967953","article-title":"Increased intrathecal neurofilament light and immunoglobulin M predict severe disability in relapsing-remitting multiple sclerosis","volume":"13","author":"Rosenstein","year":"2022","journal-title":"Front Immunol"},{"issue":"7","key":"10.1016\/j.jare.2025.02.021_b0225","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1001\/jamaneurol.2019.0905","article-title":"Association of Intrathecal Immunoglobulin G Synthesis With Disability Worsening in Multiple Sclerosis","volume":"76","author":"Gasperi","year":"2019","journal-title":"JAMA Neurol"},{"issue":"3","key":"10.1016\/j.jare.2025.02.021_b0230","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1177\/1352458517748474","article-title":"Increased cerebrospinal fluid albumin and immunoglobulin A fractions forecast cortical atrophy and longitudinal functional deterioration in relapsing-remitting multiple sclerosis","volume":"25","author":"Kroth","year":"2019","journal-title":"Mult Scler"},{"key":"10.1016\/j.jare.2025.02.021_b0235","first-page":"266","article-title":"Hydrolysis of myelin basic protein by IgM and IgA antibodies from the sera of patients with multiple sclerosis","author":"Polosukhina","year":"2005118","journal-title":"Med Sci Monit"},{"key":"10.1016\/j.jare.2025.02.021_b0240","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.764937","article-title":"Primary Peripheral Epstein-Barr Virus Infection Can Lead to CNS Infection and Neuroinflammation in a Rabbit Model: Implications for Multiple Sclerosis Pathogenesis","volume":"12","author":"Hassani","year":"2021","journal-title":"Front Immunol"},{"issue":"3","key":"10.1016\/j.jare.2025.02.021_b0245","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s10048-024-00764-w","article-title":"Hitting Epstein Barr virus where it hurts: computational methods exploration for siRNA therapy in alleviating Epstein Barr virus-induced multiple sclerosis","volume":"25","author":"Ojo","year":"2024","journal-title":"Neurogenetics"},{"key":"10.1016\/j.jare.2025.02.021_b0250","doi-asserted-by":"crossref","first-page":"777","DOI":"10.3389\/fimmu.2017.00777","article-title":"Exposure to the Epstein-Barr Viral Antigen Latent Membrane Protein 1 Induces Myelin-Reactive Antibodies In Vivo","volume":"8","author":"Lomakin","year":"2017","journal-title":"Front Immunol"},{"issue":"20","key":"10.1016\/j.jare.2025.02.021_b0255","doi-asserted-by":"crossref","first-page":"4875","DOI":"10.1523\/JNEUROSCI.5584-03.2004","article-title":"Infection with an endemic human herpesvirus disrupts critical glial precursor cell properties","volume":"24","author":"Dietrich","year":"2004","journal-title":"J Neurosci"},{"key":"10.1016\/j.jare.2025.02.021_b0260","first-page":"305","article-title":"Animal Models","volume":"12","author":"Genain","year":"2006","journal-title":"Perspect Med Virol"},{"key":"10.1016\/j.jare.2025.02.021_b0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.virusres.2022.198726","article-title":"The dysregulation of autophagy and ER stress induced by HHV-6A infection activates pro-inflammatory pathways and promotes the release of inflammatory cytokines and cathepsin S by CNS cells","volume":"313","author":"Romeo","year":"2022","journal-title":"Virus Res"},{"key":"10.1016\/j.jare.2025.02.021_b0270","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2017.00535","article-title":"The Role of Fungi in the Etiology of Multiple Sclerosis","volume":"8","author":"Benito-Le\u00f3n","year":"2017","journal-title":"Front Neurol"},{"issue":"9","key":"10.1016\/j.jare.2025.02.021_b0275","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1007\/s10096-010-0979-y","article-title":"Association between multiple sclerosis and Candida species: evidence from a case-control study","volume":"29","author":"Benito-Le\u00f3n","year":"2010","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.jare.2025.02.021_b0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.109721","article-title":"Dimethyl fumarate ameliorates fungal keratitis by limiting fungal growth and inhibiting pyroptosis","volume":"115","author":"Gu","year":"2023","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.jare.2025.02.021_b0285","doi-asserted-by":"crossref","unstructured":"Mezzaroba L, Sim\u00e3o ANC, Oliveira SR, Flauzino T, Alfieri DF, de Carvalho Jennings Pereira WL, et al. Antioxidant and Anti-inflammatory Diagnostic Biomarkers in Multiple Sclerosis: A Machine Learning Study. Molecular Neurobiology. 2020;57(5):2167-78. doi: 10.1007\/s12035-019-01856-7.","DOI":"10.1007\/s12035-019-01856-7"}],"container-title":["Journal of Advanced Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2090123225001195?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2090123225001195?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T18:07:58Z","timestamp":1778522878000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2090123225001195"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":57,"alternative-id":["S2090123225001195"],"URL":"https:\/\/doi.org\/10.1016\/j.jare.2025.02.021","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2024.11.16.24317434","asserted-by":"object"}]},"ISSN":["2090-1232"],"issn-type":[{"value":"2090-1232","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Autoimmune responses to myelin-associated proteins as diagnostic and prognostic biomarkers of relapsing-remitting multiple sclerosis: Associations with human herpesvirus-6 and Epstein-Barr virus reactivation","name":"articletitle","label":"Article Title"},{"value":"Journal of Advanced Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jare.2025.02.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier B.V. on behalf of Cairo University.","name":"copyright","label":"Copyright"}]}}